#
CONTENTS
• Introduction
• Calcium
•Dietary requirements
• Sources
• Functions
• Homeostasis of calcium
• Calcitriol
• Parathyroid hormone
• Calcitonin
• Calcium absorption
• Disorders due to Changes in Ca levels
• Investigations of bone and Ca disorders
• Prosthodontic considerations
• Conclusion
4.
#
Introduction
• Mineral (inorganic)elements constitute
only small proportion of body weight.
• Minerals - Principal elements (60-80%)
- Trace elements
• 7 principal elements are Calcium,
Phosphorus, Magnesium, Sodium,
Potassium, Chloride & Sulfur
5.
#
Calcium
• Most abundantmineral in the body.
• Constitutes about 2% of body weight.
• Total content of Ca in adult is 1-1.5kg.
• 99% - bones & teeth.
• 1% - body fluids.
6.
#
Plasma calcium
• Mostof the blood Ca is in plasma.
• Normal conc – 9-11 mg/dl.
• 5mg/dl – ionised form – most active.
• 1mg/dl – in association with citrate & P.
• 4-5mg/dl – bound to protien.
• Ionised & citrate bound – diffusible
• Protien bound – non-diffusible.
7.
#
Dietary requirements
• Adultmen & women – 800mg/day
• Pregnant, lactating &post menopausal
women – 1.5 g/day.
• Children (1-18yrs) – 0.8-1.2 g/day
• Infants (<1yr) – 300-500 mg/day
8.
#
Sources
• From milkand milk products.
• And also beans, leafy vegetables, fish,
cabbage, egg yolk.
9.
#
Biochemical functions
• Developmentof bones and teeth
• Muscle contraction
• Blood coagulation
• Nerve transmission
• Membrane integrity and permeability
• Activation of enzymes(lipase, ATPase,
succinate dehydrogenase).
10.
#
• Calcium asintracellular messenger.
Second messanger in liver
glycogenolysis & third messanger for
some hormones like ADH which acts
through cAMP & then Ca.
• Release of hormones (insulin, PTH,
calcitonin)from endocrine glands.
• Acts on myocardium and prolongs
systole.
#
Homeostasis Of Calcium
•Calcium is almost exclusively present in
blood plasma or serum.
• The hormones Calcitriol, Parathyroid
hormone, Calcitonin are major factors
that regulate plasma calcium
(homeostasis of Ca) within normal
range.
13.
#
Calcitriol
• Active formof vit-D or
1 ,25-
dihydroxycholecalciferol
• Skin-photoactivation of
7-dehydrocholesterol to
cholecalciferol (D3)
Liver-25-
hydroxycholecalciferol –
Kidneys – by 1 –
hydroxylase to 1,25-
dihydroxycholecalciferol
(conversion is mediated
by PTH)
14.
#
FUNCTIONS
to increaseplasma calcium
increases absorption of Ca in
intestines stimulates formation of
calcium-binding protein in epithelial
cells.
promotes bone calcification and
deposition by stimulating ca uptake by
osteoblasts.
inhibits secretion of PTH.
15.
#
Role of Calcitriol
•Stimulates GI absorption of both calcium
and phosphate
• Stimulates renal reabsorption of both
calcium and phosphate
• Stimulates bone resorption
Net effect of calcitriol - ↑ serum calcium
↑ serum
phosphate
16.
#
Parathyroid Hormone
• Parathyroidglands
• Single chain polypeptide -84 AA
• Synthesised as preproPTH –
degraded to proPTH – active PTH
• Formation and secretion of PTH is
promoted by low ca conc.
• Stimulus for secretion of PTH
– low plasma calcium
17.
#
• PTH actson 3 independent tissues
• Bone – demineralisation by osteoclasts.
this is by PTH stimulated activity of enzymes
pyrophosphate & collagenase which cause
bone resorption. This leads to blood Ca
levels.
• Kidney- PTH Ca reabsorption by kidney
tubules. PTH promotes production of calcitriol
by stimulating 25-hydroxycholecalciferol by 1
hydroxylase.
• Intestine – PTH increases intestinal
absorption of Ca by promoting synthesis of
calcitriol.
18.
#
FUNCTIONS
to increaseplasma calcium
activation of osteoclasts – stimulates
absorption of Ca, P from bones
decreases excretion of Ca by kidneys
increases excretion of P by kidneys
stimulates conversion of vitamin D to
calcitriol (vitamin D hormon) in kidneys
19.
#
Role of PTH
•Stimulates renal reabsorption of calcium
• Inhibits renal reabsorption of phosphate
• Stimulates bone resorption
• Inhibits bone formation and
mineralization
• Stimulates synthesis of calcitriol
Net effect of PTH - ↑ serum calcium
↓ serum phosphate
20.
#
Calcitonin
• Parafollicular cellsof thyroid gland (C-
cells).
• peptide containing 32 amino acids.
• stimulus for secretion – high plasma
calcium.
• Promotes calcification by increasing
activity of osteoblasts.
21.
#
FUNCTIONS
to decreaseplasma calcium and
phosphates
inhibits osteolysis – decreases
absorption of Ca, P from bones
stimulates incorporation of Ca, P to
bones
decreases absorption of Ca, P in
kidneys
decreases the effect of PTH on bones
– PTH antagonist
22.
#
Calcium Absorption
Absorption ofCa occurs in duodenum by
energy dependent active process.
Factors promoting Ca absorption
1. Vit-D induces synthesis of Ca binding
protein in intestinal epithelial cells &
promotes Ca absorption.
2. PTH – by synthesis of calcitriol.
23.
#
3. Acidity (lowpH)
4. Lactose promotes Ca uptake by
intestinal cells.
5. AA Lysine & Arginine.
Factors inhibiting ca absorption
1. Phytates & oxalates by forming
insoluble salts.
2. High content of dietary P results in
formation of insoluble Ca P &prevents
Ca uptake.
24.
#
• Alkaline (highpH)
• High content of dietary fiber interferes
with Ca absorption.
• Free fatty acids react with Ca to form
insoluble Ca soaps.
#
Dental considerations
• Dentaltreatment complicated by-
tetany, seizures, psychiatric problems &
learning disability.
• There may be facial parasthesia &facial
twitching caused by tetany (chvostek’s
sign).
• Local anesthesia satiafactory
• Consious sedation after replacement
therapy
27.
#
Hypercalcemia
• Serum calciumlevel elevated
• Associated with hyperparathyroidism in
which there is serum phosphate and
also alkaline phosphatase activity.
• Diagnosis can be done by determination
of ionised serum calcium level
(elevated to 6-9mg/dl) .
28.
#
Conditions associated:
• Depressionof nervous system, reflex
activity.
• Increased heart contractility.
• Lack of appetite & constipation.
• Abdominal pain, peptic ulcers
• Formation of calcium phosphate
crystals(urinary calculi).
• Bone diseases like osteitis fibrosa
cystica.
29.
#
Dental considerations
• Dentaltreatment complicated by renal
diesease, peptic ulcer & bone frgility.
• LA main means of pain control.
• Conscious sedation with nitrous oxide &
O2.
• General anesthesia complicated b’cos
of cardiovascular complications and
sensitivity to muscle relaxants.
30.
#
Osteoporosis
• Disease –low bone mass and micro-
architectural deterioration of bone
tissue, leading to enhanced bone
fragility and an increase in fracture
risk.
• Most common in advanced age and
also women are more prone b’cos of
loss of estrogen production which
accelarates bone loss.
31.
#
Causes
• Etiology unknown
•May be due to the ability to produce
calcitriol from vitamin-D is decreased
with age.
• Immobilised or sedentary individuals
tend to decrease bone mass.
• Post menopausal, deficiency of
oestrogen has implicated in
development of osteoporosis.
32.
#
Clinical features
• Mildtaumatic or non-traumatic injuries
cause fractures
• Chief complications- fracture of neck of
femur, distal radius or humerus, or
vertebral bodies causing gradual
collapse of spine.
• Low back pain.
33.
#
Risk factors
-Increasing age
-Earlymenopause
-Female sex
-Immobility
-Smoking
-Excess alcohol
-Nutrition(low ca diet,
high protein intake for
long time)
Diseases
Endocrine
-Cushing syndrome
-Hyperparathyroidism
-Hypogonodism
-Acromegaly
-typeI diabetes mellitus
Joint
-Rheumatiod arthritis
Other
-Chronic liver failure
-Chronic renal failure
-Mastocytosis
-Anorexia nervosa
-Inflammatory bowel disease
-Coeliac disease
Drug therapy
-Corticosteroids
-Heparin
-Ciclosporin
-Cytotoxics
34.
#
Investigations
• If fractureis suspected
- plain radiographs.
- bone scintigraphy(pelvis or vertebrae
fracture)
• Bone density – DXA(dual energy x-ray
absorptiometry)
35.
#
Dental considerations
• Thereseems to be correlation between
osteoporosis and excessive alveolar bone
loss in elderly edentulous patients.
• Jaw osteoporosis is particularly a problem in
women.
• Systematic treatment may improve jaw bone
density.
• There may be risk during general anesthesia,
if there is vertebral collapse and chest
deformities
36.
#
Treatment
• Diet with1000mg of Ca daily
and 400-800 IU of vit-D.
• 30min of wt bearing
exercises 3 times a week.
• Smoking cessation
• Hormone replacement
therapy.
• Combination therapy of
calcium with vitamin-D.
37.
#
Rickets & Osteomalacia
•Inadequate mineralisation of bone
matrix.
• Usually caused by a defect in vit-D
availability or metabolism.
• In children calcification delayed &
vascularisation impaired.
• In adults osteiod width & delayed
mineralisation assessed by double-
tetracycline labelling.
38.
#
Etiology
Rickets
• In urbanareas that were
deprived of sunlight.
• Failure of vit-D synthesis
in skin.(lack of exposure
to sun light).
Osteomalacia
• Postmenopausal women
with history of low dietary
calcium intake and little
exposure to ultra violet
rays.
#
Clinical features
Osteomalacia-
• Remodellingof bone in absence of adequate calcium
– results in softening and distortion of skeleton and
an increased tendency to fracture
• Vague symptoms of bone or muscle pain and
tenderness.
• Fractures rare and asymptomatic.
• Proximal myopathy- waddling gait.
• Occasionally, tetany or other hypocalcemic features.
41.
#
Clinical features
Rickets
• Atbirth- craniotabes (thin
deformed skull)
• First few years of life- widened
epiphysis at wrists and beading at
costochondral junctions, producing
‘rickety rosary’ or harrison’s sulcus
(groove in mid rib).
• In older children lower limb deformities.
#
Dental considerations
• Dentaldefects seen in unusally severe
cases, eruption may be retarded.
• Jaws shows abnormal radiolucency.
• Vit-D deficient rickets, skull suture are
wide and frontal bossing present which
are known mostly by dental complaints.
• Teeth – large pulp chambers &
abnormal dentin calcification –liable to
pulpitis and dental abscesses.
44.
#
Treatment
• Increase indietary vit-D intake and
sunlight exposure.
• Also multiple formulations of vit-D and
its metabolites are available.
• Nutritional deficiency-replacement
doses needed - 400-800 IU daily.
• Gasterectomy malabsorption, liver
disease or hypoparathyroidism – upto
40,000-100,000 IU
45.
#
Investigations of boneand
calcium disorders
• Total plasma calcium (9-11mg/dl)
• PTH & 25-hydroxyvit-D – useful where
hypervitaminosis D or interaction with
antiepileptic drugs is suspected in
hypocalceamia or in hypercalceamia.
• Urinary calcium
(normal-2.5-7.5mmol/24hrs) – increased
when renal tubular resorption of Ca is
decreased or in hypercalceamia.
46.
#
• Markers ofbone formation
– Alkaline phosphatase
– Serum osteocalcin
– Type I collagen propeptides
• Markers of bone resorption
-Pyridinoline cross links of collagen
-N-terminal and C-terminal
crosslinked telopeptides
• Diagnostic imaging
-Plain radiographs
-Radionuclide scans
-Magnetic resonance imaging
47.
#
• Bone densitymeasurements
-Conventional radiographs
-Dual energy x-ray absorptiometry
-Quantitative Ctscan
-Quantitative ultrasound
• Bone biopsy
48.
#
Conclusion
• Calcium playsa key role in many physiologic
processes, including contraction of muscles, blood
clotting, transmission of nerve impulse etc.
• 0.1 % of total body calcium is in extracellular fluid,
1% in the cells and rest is stored in bones.
• Many hormones regulate Calcium homeostasis and
any abnormalities in this process could lead to hyper
or hypo calcemic states leading to altered functions
49.
#
Conclusion
• Residual ridgeresorption is a primary concern in
edentulous elderly patients and the effects of
hormones and other physical factors should be
remembered when considering prosthodontic
treatment.
50.
#
References
• Hirai T,Ishijima T, Hashkawa Y, Yajima T: Osteoporosis and
reduction of residual ridge in edentulous patients. J Prosthet
Dent. 1993 Jan;69(1):49-56.
• Zmysłowska, Ledzion, Jędrzejewski: Factors affecting
mandibular residual ridge resorption in edentulous patients: a
preliminary report. Folia Morphol. Vol. 66, No. 3, pp. 346–352
• Deshpande s, sarin p: Evaluation of the relationship between
Systemic osteoporosis, dietary ca intake and the reduction of
Residual ridges in an edentulous patient:an in vivo pilot study.
Journal of Clinical and Diagnostic Research. 2009
Aug;7(3):1706-1708.
• Wowern N, Lollerup G: Symptomatic osteoporosis: a risk factor
for residual ridge reduction of the jaws. J Prosthet Dent. 1992
May;67(5):656-60.
51.
#
References
• Shipley, BlackCM, Comptson J and O’ Gradaigh:
Rheumatology and bone disease. In: Praveen Kumar, Micheal
Clark (eds) Clinical Medicine, 5th
edition, Saunders, 2002.
• Scully C, Cawson RA: Medical Problems in dentistry, 5th
edition,
Elsevier, 2005.
• Neville, Damm, Allen, Bouquot: Oral and maxillofacial pathology,
2nd
Edition, Elsevier, 2004.
• Shafer, Hine, Levy: A text book of Oral Pathology, 4th
edition, A
prism India edition, 1993.
• Sembulingam K, Sembulingam P: Essentials of medical
physiology, 3rd
edition, Jaypee, 2004.
• Chaudhary: Consise medical physiology.
• Satyanarayana U: Biochemistry, 2nd
edition, Books and allied pvt
ltd, 2002.